H.Res. 372 is a simple, nonbinding House resolution that recognizes the harms of menstrual stigma and expresses support for designating May as “National Menstrual Health Awareness Month.” The resolution states goals—normalizing menstruation, improving education and access to care, and encouraging standards for menstrual health—and calls attention to research gaps and sanitation needs without creating new federal programs or funding.
This matters to health advocates, school and workplace administrators, researchers, and public-health planners because the resolution frames menstrual health as a cross-cutting equity and infrastructure issue. While symbolic, the text consolidates specific policy priorities—education, access to products and sanitation, and expanded clinical research—that interested actors can use to press for concrete changes at the agency, state, or institutional level.
At a Glance
What It Does
The bill is a House resolution that formally supports establishing May as National Menstrual Health Awareness Month and lists four goals: end stigma, educate young people, develop supportive standards, and improve access to care for menstrual conditions. It also contains findings about global and domestic menstrual health challenges and urges attention to sanitation and research.
Who It Affects
Primary audiences are educators, public-health officials, researchers focused on uterine and menstrual conditions, school and workplace managers responsible for sanitation and product access, and advocacy organizations working on gender equity and global health.
Why It Matters
Although nonbinding, the resolution consolidates federal-level priorities and language that advocates, agencies, and funders can cite when shaping curricula, workplace policies, sanitation upgrades, or research agendas. It places menstrual health alongside other recognized public-health equity issues, making it easier to justify programmatic attention.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
H.Res. 372 is a commemorative, non-legislative resolution that compiles a set of factual findings and policy priorities about menstruation and menstrual health. The text opens with a series of ‘‘whereas’’ clauses that document international and domestic burdens—citing a World Bank estimate of half a billion people lacking access to menstrual supplies and sanitation, the United Nations Population Fund’s framing of menstruation as linked to human dignity, and a domestic statistic about daily entries into menopause—to build a factual case for attention.
The operative language does not create new rights or funding. Instead, the resolution uses five short ‘‘resolved’’ paragraphs: one formally endorses the goals of a National Menstrual Health Awareness Month and spells out four specific goals (normalizing menstruation, educating young people, developing standards for menstrual health education and care, and improving access to treatment and information for conditions like dysmenorrhea, fibroids, endometriosis, and polycystic ovary syndrome).
The following paragraphs acknowledge the importance of access to products and private sanitation in schools and workplaces (including abroad), call for promoting health equity by addressing stigma, and encourage expanded clinical research and education on menstrual-impacting conditions. It concludes by supporting the designation of May as the awareness month.Because this is a House resolution (H.Res.), it is symbolic and nonbinding: it does not appropriate funds, impose regulatory obligations, or amend substantive statutory law.
Its practical effect lies in signaling congressional priorities. Policymakers, agency staff, school districts, and funders may cite the resolution when proposing program changes or applying for grants; advocacy groups can use the language to lobby for targeted investments in sanitation infrastructure, menstrual-product provision, school curricula, and medical research focused on uterine and menstrual conditions.The resolution’s combination of global statistics, explicit naming of medical conditions, and specific calls for standards and education gives it more operational texture than a generic awareness resolution.
That texture makes it a potential lever for actors who already control budgets or rulemaking authority—state education agencies, the Department of Health and Human Services, school districts, and private foundations—to justify specific initiatives during or following the designated month.
The Five Things You Need to Know
The resolution enumerates specific menstrual conditions—dysmenorrhea, fibroids, endometriosis, and polycystic ovary syndrome—as areas where access to care and information should improve.
It lists four explicit goals for the awareness month: normalize menstruation and eliminate stigma; educate young people about menstrual health management; develop supportive standards for education and care; and improve access to treatment and information.
The ‘‘whereas’’ clauses cite international data, including a World Bank estimate that 500 million people lack adequate menstrual products and sanitation, and reference the United Nations Population Fund on menstrual dignity.
The resolution was referred to the House Committee on Energy and Commerce and the Committee on Education and Workforce for consideration of provisions within their jurisdictions.
H.Res. 372 is nonbinding and contains no appropriation language—its effect is declaratory and agenda-setting rather than regulatory or fiscal.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings documenting stigma, global access gaps, and research shortfalls
This cluster of findings assembles international and domestic data—global estimates of inadequate menstrual supplies and sanitation, UNFPA statements about dignity, and domestic statistics such as daily entries into menopause—to justify congressional attention. For practitioners, these clauses are the evidentiary hook: they provide cited facts advocates and agencies can quote when seeking funding or policy change.
Official endorsement of four programmatic goals
Paragraph 1 formally supports the awareness month and breaks the initiative into four actionable goals: destigmatize menstruation, educate youth, develop standards for education and care, and expand access to treatment and information for named conditions. Each subpoint provides a clear set of priorities that program designers can translate into curricula, clinical guidelines, or awareness campaigns.
Calls for appropriate menstrual products and private sanitation in schools and workplaces
This paragraph explicitly acknowledges infrastructure needs in both domestic and international contexts. For school districts and employers, the language highlights sanitation and product access as areas for potential policy or capital investment; for aid agencies and NGOs, it reinforces that menstrual management is a legitimate component of international health and WASH (water, sanitation, and hygiene) programming.
Focus on health equity and expanded clinical research
These two paragraphs emphasize stigma’s disproportionate burdens and call for more clinical study and education on menstrual-impacting conditions. Operationally, the text pressures research funders and public-health agencies to consider menstrual conditions in priority-setting, and it provides an authoritative rationale for grant proposals and research agendas addressing fibroids, endometriosis, PCOS, and menopause-related issues.
Support for designating May as National Menstrual Health Awareness Month
The final operative paragraph simply supports naming May the designated month. The mechanics are ceremonial: the designation does not itself trigger programs or funding, but it creates a recurring timeframe that agencies, nonprofits, and institutions can use to coordinate outreach, educational rollouts, or fundraising drives tied to menstrual-health priorities.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Students and school-aged youth: explicit calls for education and improved sanitation give school districts and educators a policy rationale to introduce menstrual-health curricula and provide private facilities and products.
- Patients with menstrual and uterine conditions: naming dysmenorrhea, fibroids, endometriosis, and PCOS raises visibility and can be used by clinicians and advocates to argue for research funding and better diagnostic pathways.
- Advocacy organizations and public-health nonprofits: the resolution provides a congressional statement they can cite when lobbying for programmatic funding, school policy changes, or international WASH interventions.
- International health and WASH programs: the document’s global statistics and language on sanitation strengthen the case for donors and agencies to include menstrual supplies and facilities in foreign assistance and development projects.
Who Bears the Cost
- School districts and employers: while the resolution imposes no legal mandate, it increases pressure on these institutions to provide products, private sanitation, and education—actions that carry operational and budgetary costs.
- State and local health agencies: agencies may face expectations to develop standards or guidance responsive to the resolution without additional federal funding, creating an unfunded implementation burden.
- Research funders and institutions: the push for expanded clinical research may require reallocating limited research dollars or creating new grant programs, which could shift funding away from other priorities.
- Federal program administrators and grantmakers: the visibility created by the resolution could prompt increased inquiries and grant applications, requiring administrative attention and review capacity.
Key Issues
The Core Tension
The central dilemma is symbolic recognition versus substantive change: the resolution amplifies legitimate public-health and equity concerns and sets a clear agenda, but without funding or binding requirements it risks creating expectations that cannot be met without additional legislative or administrative action—forcing stakeholders to choose between aspirational goals and realistic implementation plans.
The resolution’s biggest practical limitation is its lack of fiscal or regulatory teeth. It declares priorities and names medical conditions, but it does not appropriate funds, create reporting duties, or change regulatory standards—so any downstream programs will require separate legislation, agency action, or reallocation of existing budgets.
That creates a common implementation gap: expectations are raised while concrete resources remain absent.
Another tension concerns scope and operationalization. The resolution uses inclusive language—‘‘women, girls, and people who menstruate’’—and links menstrual health to international WASH issues, education, and clinical research.
Translating that broad, cross-sector framing into measurable policy requires choices about target populations, age groups, and program boundaries (for example, which school levels receive curricula, which workplace settings must upgrade facilities, or which research topics receive priority). Those choices will expose trade-offs between competing public-health and budgetary priorities.
Finally, the resolution’s citation of international statistics and calls for sanitation can push U.S. foreign assistance actors to integrate menstrual health into programs, but it also raises questions about metrics and accountability: what counts as ‘‘access’’ to products or as an adequate sanitation facility, and who measures it? Without agreed definitions, program design risks fragmentation and inconsistent outcomes across jurisdictions.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.